Altered Expression of γ‐Glutamylcysteine Synthetase, Metallothionein and Topoisomerase I or II during Acquisition of Drug Resistance to Cisplatin in Human Ovarian Cancer Cells
Authors:
Open Access
- 1 February 1997
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 88 (2) , 213-217
Abstract
This study was designed to elucidate the mechanisms of cisplatin (CDDP) resistance using two human ovarian cancer cell lines, KF and TYK, and two CDDP‐resistant lines, KFr and TYK/R, derived from the former lines. KFr and TYK/R showed about 3‐fold higher resistance to the cytotoxic effects of CDDP than their parental lines. They also showed a significant increase in sensitivity to not only etoposide, but also (+)‐(4S)‐4, ll‐diethyl‐4‐hydroxy‐9‐[(4‐piperidino‐piperidino)carbonyloxy]‐lH‐pyrano[3′,4′:6,7]inodolizino[l,2‐b]quinoline‐3,14(4H, 12H)‐dione hydrochloride trihydrate (CPT‐11). Cellular CDDP accumulation levels in KFr and TYK/R were decreased from those of the parental cells. By contrast, the cellular glutathione (GSH) content in KFr cells was 1.7‐fold higher than that in KF, whereas TYK/R cells had a 40% lower content than TYK cells. Cellular mRNA levels of drug‐resistance‐related genes, such as DNA topoisomerase (topo) I and topo II, glutathione S‐transferase‐π (GST‐π;), γ‐glutamylcysteine synthetase (.γ‐GCS), and metallothionein (hMT) genes, were compared between drug‐sensitive KF or TYK and KFr or TYK/R. KFr cells had 8.5‐ and 24.7‐fold higher mRNA levels of γ‐GCS and topo II genes than KF cells while KFr had only a slight increase in GST‐π mRNA level as compared with KF. By contrast, TYK/R cells had 2.9‐ and 1.7‐fold higher hMT and topo I mRNA levels than TYK cells. Acquisition of CDDP resistance in human ovarian cancer cells thus appeared to be related mainly to expression of γ‐GCS, topo II and hMT genes, and partly to that of topo I and GST‐π genes, in addition to a decrease in CDDP accumulationKeywords
This publication has 21 references indexed in Scilit:
- Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.1994
- Modulation of sensitivity of human ovarian cancer cells to cis‐diamminedichloroplatinum(II) by 12‐O‐tetradecanoylphorbol‐13‐acetate and D, L‐buthionine‐S, R‐sulphoximineInternational Journal of Cancer, 1993
- Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetaseBiochemical and Biophysical Research Communications, 1992
- High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.Proceedings of the National Academy of Sciences, 1992
- Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemiaCancer Chemotherapy and Pharmacology, 1991
- In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell lineJournal of Cancer Research and Clinical Oncology, 1990
- Possible Mechanisms of Resistance to cis‐Diamminedichloroplatinum (II) of Human Ovarian Cancer CellsJapanese Journal of Cancer Research, 1990
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridineAnalytical Biochemistry, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970